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Background: Set2 catalyzes mono-, di-, and trimethylation of lysine 36 on histone H3 (H3K36).
Results: Phosphorylation of the C-terminal domain of RNA polymerase II (RNAPII CTD) regulates Set2 protein levels and
H3K36 methylation.
Conclusion: Set2 protein is regulated to maintain balanced levels of H3K36 methylation.
Significance: These results suggest that different methylation states perform distinct biological functions.
Methylation of lysine 36 on histone H3 (H3K36) is catalyzed
by the Set2 methyltransferase and is linked to transcriptional
regulation. Previous studies have shown that trimethylation of
H3K36 by Set2 is directed through its associationwith the phos-
phorylated repeats of the RNA polymerase C-terminal domain
(RNAPII CTD). Here, we show that disruption of this interac-
tion through the use of yeast mutants defective in CTD phos-
phorylation at serine 2 results in adestabilizationof Set2protein
levels andH3K36methylation.Consistentwith this, we find that
Set2 has a short half-life and is co-regulated, with RNAPII CTD
phosphorylation levels, during logarithmic growth in yeast. To
probe the functional consequence of uncoupling Set2-RNAPII
regulation, we expressed a truncated and more stable form of
Set2 that is capable of dimethylation but not trimethylation in
vivo. Results of high throughput synthetic genetic analyses show
that this Set2 variant has distinct genetics from either SET2 or
set2 and is synthetically sick or lethal with a number of tran-
scription elongationmutants. Collectively, these results provide
molecular insight into the regulation of Set2 protein levels that
influence H3K36 methylation states.
The N-terminal tails of histones are richly decorated with
post-translational modifications that regulate a variety of
DNA-templated processes through the recruitment of addi-
tional factors to chromatin. These factors interact with modifi-
cations such as acetylation, methylation, and phosphorylation
through specific protein domains such as bromo-, chromo-,
PHD, and TUDOR domains (1). Furthermore, these domains
are usually found in the context of multiprotein complexes that
perform diverse functions in chromatin remodeling, replica-
tion, transcription, andDNA repair, among others (2–4). Thus,
there is great interest in both identifying biological important
post-translational modifications on histones and understand-
ing how these modifications function within chromatin.
One such post-translational modification is methylation of
lysine 36onhistoneH3. In yeast,H3K363 ismodified by themeth-
yltransferase Set2,which can addone, two, or threemethyl groups
to the -amino group of the lysine side chain using S-adenosylme-
thionineas themethyl donor (5).Genome-widechromatin immu-
noprecipitation studies have demonstrated that H3K36 methyla-
tion is generally associated with actively transcribed genes;
however, dimethylation (H3K36me2) and trimethylation
(H3K36me3) show different patterns of localization (6–8).
H3K36me2 appears uniformly distributed across transcribed
genes and is not correlated with transcription frequency, whereas
H3K36me3 seems to be most prevalent at the 3 end of coding
regions and is positively correlated with the rate of transcription.
These data suggest that the deposition of different levels ofH3K36
methylation is controlled within the cell and that the different
degrees of this modification likely direct distinct biological
functions.
H3K36 methylation has been reported to be recognized by
the Rpd3(S) deacetylase complex in Saccharomyces cerevisiae
through the chromodomain of Eaf3 (a member of both the
Rpd3(S) deacetylase and NuA4 histone acetyltransferase com-
plexes) (9–11). Subsequent studies revealed that H3K36me2 is
the preferred substrate for Rpd3(S) binding (12–14) and that a
primary function for H3K36 methylation is to recruit the
repressive activity of Rpd3(S) to genes to “reset” or reestablish
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chromatin structure between multiple rounds of transcription
(15–17). Such resetting, or at leastmaintaining amore compact
chromatin structure within gene bodies, also protects genes
from spurious transcription from improper initiation sites
(cryptic transcription) (15–18). To date, no separate function
has been reported for H3K36me3. However, H3K36me3 can be
recognized by both the chromodomain of Eaf3 and in vitro by
the PHD domain of Nto1, a member of the NuA3 histone
acetyltransferase complex, suggesting that H3K36me3 might
have a positive role in transcription through the recruitment of
histone acetyltransferase complexes (19). Consistent with this,
NuA3 association to chromatin has been shown to be partially
dependent on Set2 methylation (20).
Set2 interacts with the repeating C-terminal domain (CTD)
of RNA polymerase II (RNAPII) (12, 21–25). In yeast, the CTD
of RNAPII consists of 26 repeats of a heptapeptide repeat
sequence (YSPTSPS) in which all three serine residues can be
phosphorylated (26–28). Set2 preferentially recognizes the
Ser2/Ser5-modified form of the CTD through a region at the C
terminus of Set2 termed the SRI (Set2-Rpb1 interacting)
domain (21, 29). Consistent with this, H3K36me3 is well corre-
lated with Ser2- and Ser2/Ser5-modified forms of the CTD that
occur within the bodies and 3 ends of genes (6, 30–32).
We recently reported that deletion of the kinase responsible
for Ser2 phosphorylation of the CTD, Ctk1, results not only in
loss of H3K36me but also decreased Set2 protein levels (14).
This finding suggested a novel mechanism for regulating his-
tone methyltransferase activity. Here, we present a molecular
basis for the regulation of Set2 protein levels. We find that
events that alter or perturb Ser2 CTD phosphorylation levels
result in reduced levels of Set2 protein and global loss of
H3K36me3withoutmuch change inH3K36me2. Furthermore,
we demonstrate that expression of a stable truncation of Set2,
incapable of H3K36me3, greatly compromises the growth of
several transcription elongationmutants. Lastly, high through-
put epistatic (E-MAP) analysis reveals different interactions for
strains capable of catalyzing different levels of H3K36methyla-
tion in vivo. Collectively, our data delineate a novel mechanism
for Set2 regulation and support themodel that different degrees
of H3K36 methylation likely harbor distinct functions.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids—Strains used in this study are
detailed in supplemental Table S1. Strains created for this study
were constructed using heterologous gene replacement (33, 34)
or through classical yeast mating in combination with tetrad
dissection or high throughput strain construction techniques
(35). Set2 expression plasmids (14, 21) were transformed using
the lithium chloride technique (36), and shuffle strains (where
important genes were genomically deleted but carried on a ura-
cil-selectable plasmid) were maintained on selective media
until the time of the appropriate experiment, and plasmid loss
was instigated by plating on media containing 5-fluoroorotic
acid (5-FOA) (37).
Western Blot Analysis—Yeast cultures were grown in either
rich medium (YPD) or synthetic defined medium from a start-
ing A600 of between 0.1 and 0.2 and grown to mid-log phase
(A600 0.6–1.0) with the exception of cultures started from sta-
tionary phase. In this instance, 200-ml cultures were started
from saturated cultures of yeast grown in synthetic defined
medium for 7 days and inoculated at an initial A600 of 0.5. In
all cases, five optical units of cells were harvested by centrifu-
gation, and extracts were prepared using a protocol adapted
from Ref. 38. Briefly, cell pellets were resuspended in 75 l of
SUMEB buffer (1% SDS, 8 M urea, 10mMMOPS, pH 6.8, 10mM
EDTA, 0.01% bromphenol blue), mixed with 200 l of glass
beads, and vortexed for 3min. To the beadswas added 175l of
additional buffer, and the total supernatant was collected and
clarified to give a total volume of 250 l of cell extract. Extracts
were heated at 95 °C for 5 min and frozen at 80 °C until use.
For Western blot analysis of histones, 5 l of extract was sepa-
rated by 17% SDS-PAGE. For Western analysis of Set2 and
RNAPII, proteins were separated by 8% SDS-PAGE. Gels were
transferred to PVDF for 90min at 45mA and dried inmethanol
to block according to the manufacturer’s instructions (Milli-
pore-Immobilon-P). Driedmembranes were rehydrated briefly
in methanol and incubated with primary antibodies overnight
at 4 °C in PBST (phosphate-buffered saline including 0.05%
Tween 20) containing 5% blocking (Pierce). Antibodies were
used at the following dilutions: anti-H3K36me2 (ActiveMotif),
1:1,000; anti-H3K36me3 (Abcam ab9050), 1:2,500; anti-H3
1:5,000; anti-Set2 (1:8,000), anti-G6PDH (1:100,000), anti-
Ser(P)2 CTD (gift of D. Eick), 1:200. Western blots were visual-
ized using HRP-conjugated secondary antibodies and ECL Plus
chemiluminescence (GE Healthcare).
Protein Turnover Experiments—Turnover experiments were
adapted from a protocol from Ref. 39. Briefly, 100-ml cultures
of yeast in YPD were grown to an A600 of 0.6, and cyclohexi-
mide was added to a final concentration of 200 g/ml. Five
optical units of cells were taken at various time points, and 1ml
of 10 mM sodium azide and 1 ml of dimethyl sulfoxide were
added. Cells were then immediately frozen in liquid nitrogen.
Frozen samples were thawed simultaneously, and extracts were
prepared using the SUMEB method described above.
Yeast Growth Assays—For phenotypic growth assays, yeast
were grown overnight in appropriate media (YPD or synthetic
completemediumwith necessary additives). Saturated cultures
were used to start fresh cultures in the samemedium at anA600
of 0.2. Cells were allowed to double at least two times, and
cells were harvested and resuspended to anA600 of 1.0 in sterile
water in a 96-well plate. Cells were 5-fold serially diluted and
then spotted onto plates containing necessary selections using a
48-pin replicating tool. Plates were incubated at indicated tem-
peratures and imaged daily.
Epistatic Miniarray Analysis—E-MAP analysis was carried
out as described (40, 41). Growth rates were assessed by auto-
mated image analysis of colony size (42).
RESULTS
Set2 and H3K36 Methylation Are Regulated Differentially
during Cell Growth—It has been well established that methyla-
tion by Set2 is correlated with hyperphosphorylation of the
CTD of RNAPII. More than a decade ago, West and Corden
showed that CTD phosphorylation was highly correlated with
log phase growth and the diauxic shift in yeast (43). We there-
foremeasured Set2 protein and histonemodifications in differ-
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ent stages of yeast growth. Starting from stationary phase cells,
a 200-ml culture of yeast in YPD was inoculated at an initial
A600 of 0.5, and time points/A600 measurements were taken at
regular intervals (Fig. 1A). Extracts from each time point were
separated by SDS-PAGE and probed for Set2 as well as RNAPII
phosphorylation and histone modifications by Western blot
analysis. As shown in Fig. 1B, and consistentwith previous find-
ings (43), RNAPII and CTD phosphorylation levels peaked at
late log phase and during diauxic shift (t  6–8 h). Signifi-
cantly, we found that Set2 protein levels also changed under
these same conditions and correlated strongly with the occur-
rence of RNAPII CTD phosphorylation (Fig. 1B). In examina-
tion of H3K36methylation levels, we observed that H3K36me2
was most abundant at t  0 and 2 h but decreased during mid-
to late log phase (Fig. 1C). In contrast, H3K36me3 levels were
lowest at t  0–4 h but increased during mid- to late log phase
at the same time where Set2 levels and CTD phosphorylation
levels increased (Fig. 1C). Although Set2 and CTD phosphory-
lation levels decreased during late log phase, H3K36me3 levels
remained constant. These data uncover that Set2 and
H3K36me2 and H3K36me3 are dynamically regulated and that
Set2 proteins levels and the occurrence of H3K36me3 are
tightly coupled to CTD phosphorylation.
Set2 Protein Levels Are Regulated in Vivo—We previously
noted that Set2 protein was lost in CTK1 delete cells (ctk1),
and this was not the result of changes in SET2 gene expression
(14, 25). These data, combined with our observation that Set2
protein levels correlatewithRNAPIICTDphosphorylation lev-
els, prompted us to explore the regulation of the Set2 protein
further. Accordingly, we examined the abundance of Set2 pro-
tein upon treatment with the translational inhibitor cyclohexi-
mide (Fig. 2A). Results showed in a time course experiment that
Set2 exhibited a rapid turnoverwith a half-life of9min (Fig. 2,
A and B). In contrast, performing the same experiment in a
temperature-sensitive proteasome-deficient strain (cim3-1) at
FIGURE 1. Set2, H3K36 methylation, and RNAPII phosphorylation levels
are dynamically regulated during cell growth. A, growth curve of wild-
type BY4741 cells in complete synthetic defined medium with approximate
growth stages. s.p., stationary phase; lag, lag phase; log, anaerobic fermenta-
tion of glucose, d.s., diauxic shift; and res., aerobic respiration of ethanol.
B, Western blot analyses of extracts from the time course shown in A, indicat-
ing the presence of RNAPII as well as phosphorylated forms of the CTD and
Set2. C, Western blot analyses from samples taken in A probing for the pres-
ence of various post-translational modifications (H3K36me2, H3K36me3,
H3K4me3, and H3K27ac) on histone H3.
FIGURE 2. Set2 is a highly unstable protein. A, Western blot analysis of a
time course experiment probing for Set2 protein levels in wild-type and pro-
teasome-deficient (cim3-1) cells following addition of the translation inhibi-
tor cycloheximide (200 g/ml). B, quantification of Set2 protein levels as a
function of time following cycloheximide treatment. Protein abundance was
calculated by densitometry of Western blot analysis and plotted as the natu-
ral log of the intensity. C, schematic of Set2 domain structure and truncation
mutants used in D. D, Western blot analyses showing the relative abundance
of Set2 and the corresponding H3K36 methylation levels of several Set2 trun-
cation mutants.
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the nonpermissive temperature showed increased stability of
Set2 (Fig. 2, A and B).
We next sought to identify the region responsible for regu-
lating Set2 stability. Using strains harboring truncation
mutants of Set2 (Fig. 2C), we were able to map the region
responsible for Set2 instability to several hundred amino acids
of unknown function between the Set2 domain and the SRI
domain responsible for interaction with RNAPII (Fig. 2D).
Interestingly, analysis of Set2 and histone methylation levels in
these strains revealed unexpected behavior of the different Set2
truncations. Deleting solely the SRI domain of Set2 (Set2(1–
618)) resulted in no significant change in the abundance of Set2
protein but also no observable H3K36me2 or H3K36me3 (Fig.
2D). However, expression of just the SET domain (1–261) of
Set2 resulted in a marked increase in Set2 protein and
H3K36me2 but no detectable H3K36me3 (Fig. 2D).
Set2 Protein Levels Are Decreased in Mutants That Alter
RNAPII CTD Phosphorylation—Set2 is known to bind to the
Ser2/Ser5-phosphorylated form of RNAPII. Because Ctk1 is the
major kinase responsible for Ser2 phosphorylation, we next
wanted to determine whether the lower Set2 protein levels
found in ctk1 strains (Fig. 3A) were related to the ability of
Set2 to bind to the CTDof RNAPII.We therefore examined the
levels of Set2 protein in a number of yeast mutants known to
alter the phosphorylation state of the CTD. Set2 protein levels
were noticeably decreased in mutants of the PAF complex,
which is known to play an important role in transcription elon-
gation and affect CTD Ser2 phosphorylation (Fig. 3B) (44). Sig-
nificantly, Set2 protein levels were only decreased in PAF
mutants that also exhibited changes in CTD Ser2 phosphoryla-
tion, cdc73, paf1, and ctr9. Decreased levels of Set2 corre-
lated with decreased levels of H3K36me3 but not H3K36me2,
consistent with themodel that CTD association is necessary for
H3K36me3 by Set2.We also note that overall histone H3 levels
are reduced in both the ctr9 and paf1 strains, likely also
resulting in the lower levels of even the cross-reacting band in
these two strains (Fig. 3B). Furthermore, Set2 levels were
decreased in a temperature-sensitive allele of Kin28, as well as
mutant alleles of the phosphatases Ssu72 (ssu72-2), Fcp1 (fcp1-1),
and the cyclin-like protein Bur2 (supplemental Fig. S1). Because
many of the mutants we tested were enzymes themselves, we
wanted to confirm that the phenotype of decreased Set2 protein
was directly due to a loss changes in its ability to recognize the
CTD rather than other potential activities of these enzymes.
Accordingly, we looked at Set2 protein levels in cells expressing
mutant forms of the RNAPII CTD itself (Fig. 3C). Each strain car-
ries an RNAPII gene with a CTD comprising wild-type repeats
(WT) ormutations at either Ser2 or Ser5 within the given number
of repeats. Again, we observed a decrease in Set2 protein levels
when a number of Ser2 or Ser5 residues within the CTD repeat
were mutated to alanine. However, we saw a strong reduction in
H3K36me3, which was accompanied by either no change or a
slight increase in the levels of H3K36me2 in these cells.
Overexpression of More Stable Form of Set2(1–261) Is Lethal
in Combination with Various Transcription Mutants—A well
studied phenotype for set2 is the ability to bypass deletion of
essential transcription factors such as members of the Bur1
complex and Spt16 (11, 45, 46). We therefore hypothesized that
Set2degradationmight alter the levels ofH3K36me2/me3 to facil-
itate transcription elongation during periods of transcriptional
stress, when, for example, chromatin compaction by Rpd3(S)
would inhibit rapid gene activation of stress response genes (47,
48). To examine this possibility, by way of using mutant forms of
Set2 that have different behaviors in degradation and H3K36me,
we expressed the different truncated forms of Set2 (see Fig. 2C) on
plasmids in abur2 set2double deletion strain harboring awild-
type copy ofBUR2 and then analyzed the growth of thesemutants
after selection for the lossof theBUR2plasmidon5-FOA(Fig. 4A).
As expected, deletion of SET2 bypasses the poor growth of bur2
strain. However, reintroduction of Set2(1–261) resulted in worse
growth than either the SET2 control or vector-only controls.
These results suggest that the inability to degrade Set2 and/or
reduce H3K36me2 levels results in impaired growth due to inap-
propriate transcriptional repression through maintained recruit-
ment of Rpd3(S). Accordingly, we next deleted RCO1 (rco1), a
unique subunit of the Rpd3(S) complex, to see whether Rpd3(S)
FIGURE 3. RNAPII CTD phosphorylation regulates Set2 protein levels.
A, Set2 protein levels as measured by Western blotting of whole cell extract
taken from WT and ctk1 strains. B, Western blots of extracts taken from PAF
complex deletions strains as well as set2 cells to measure Set2 and H3K36
methylation. Ser2phos refers to phosphorylation at Ser2 within the heptapep-
tide repeat of the RNAPII CTD. * denotes a cross-reactive band for the indi-
cated antibody. C, Set2 and H3K36 methylation levels in RNAPII CTD mutants.
S2A and S5A refer to mutations at either Ser2 or Ser5 within the CTD hepta-
peptide repeat, respectively. The number in parentheses refers to the number
of tandem repeats in a given CTD sequence. The black line between the third
and fourth lanes signifies that two unrelated lanes were removed during the
editorial process. In all cases, all of the lanes originate from the same gel.
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activity was necessary for this lethality. In fact, rco1 was able to
rescue the lethality caused by expression of Set2(1–261) in the
bur2 background (Fig. 4A).
High Throughput Genetic Analysis of Set2 Truncation
Mutants—The truncated form of Set2(1–261) offered a unique
tool to assess the biological consequence of having a stable form
of catalytically active Set2, which is not able to catalyze
H3K36me3. We therefore performed epistatic miniarray anal-
ysis against 1,534 yeast mutant strains (Fig. 4B and supplemen-
tal Table S1). Our analysis revealed several classes of interac-
tions. For example Set2(1–261) and set2 exhibit similar
negative (synthetically sick) interactions with members of the
SWR1 and PAF complexes, whereas only Set2(1–261) results in
synthetic sickness with members of the COMPASS complex
(Fig. 4B). We were able to confirm several interactions by clas-
sical genetic analysis, most notably those with SWR1 (Fig. 4C).
Five representative tetrads from crosses between set2 mutant
constructs and a swr1 strain are shown in Fig. 4C. We found
that Set2(1–261), but neither Set2-FLAG nor set2 was lethal
in combination with swr1 (Fig. 4C and Table 1). Because the
FIGURE 4. Set2(1–261) shows unique genetic interactions with transcription mutants. A, growth of bur2/set2 or bur2/set2/rco1 strains harboring
Set2 truncation plasmids plated on media to select for (URA) or against (FOA) a plasmid carrying a wild-type copy of BUR2 (pBUR2). B, genetic interactions
between set2 mutants and a subset of the yeast deletion mutant collection. Blue color denotes combined sickness in the double mutant where yellow denotes
better than expected growth (40). B, representative spores grown on YPD from the dissection of genetic crosses between swr1 and set2 mutant strains (PD,
parental ditype; NPD, nonparental ditype; T, tetratype).
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SWR1 complex is primarily responsible for depositing the his-
tone variant HTZ1 into nucleosomes, we also tested genetic
interactions between our set2 mutant constructs and HTZ1
(Table 1). In this instance, both deletion of SET2 and expression
of the Set2(1–261) construct resulted in synthetic lethality
(supplemental Table S2).
DISCUSSION
Using a combination of genetics and biochemistry, we have
uncovered a significant mechanism for the regulation of Set2
methyltransferase activity in yeast. The SRI domain is known to
bind to the CTD of RNAPII when it is phosphorylated at both
the Ser2 and Ser5 positions within the CTD repeats. It was
shownpreviously that disruption of this interaction, by deleting
the CTD kinase Ctk1, resulted in a loss of H3K36 methylation
without affecting Set2 mRNA levels (25). Here, we show that
loss of H3K36me3 results from changes in the stability of the
Set2 enzyme itself, which we demonstrate is mediated via its
interaction with the phosphorylated RNAPII CTD.
In support of a role for Set2-RNAPII interaction in governing
Set2 stability, we found that mutations in enzymes that either act
on the CTD (Ctk1, Kin28, Bur1, Ssu72, Fcp1), ormutations to the
CTD sequence itself resulted in lower levels of Set2 protein and
H3K36me3 (Fig. 3 andsupplementalFig. S1). Interestingly,wealso
found that deletion of CTK1 altered the protein levels of other
factors that associate with the CTD, suggesting this mechanism
may not be restricted to just Set2 (supplemental Fig. S2).
Set2 levels correlated strongly with changes in CTD phosphor-
ylation as wild-type cells pass through log phase and into
diauxic shift (t  8–10 h) (Fig. 1, A and B). Interestingly, we
observedH3K36me2 inwhole cell extracts at time pointswhere
Set2 was barely detectible but H3K36me3 was not observed
until log phase where Set2 and CTD Ser(P)2 levels peaked (Fig.
1). These data indicate that the low levels of transcription found
in stationary phase are accompanied by low levels of Set2 and
CTD phosphorylation, yet H3K36me2 levels are maintained.
However, during rapid log phase growth where robust transcrip-
tion is needed, an increase in CTDphosphorylation accompanied
by increased stability of Set2 and H3K36me3 levels is observed.
Not only are these results consistent with previous findings that
the interaction of Set2 with the CTD is required for H3K36me3
(14), but they provide important insight into the dynamic regula-
tion of H3K36me2 versus H3K36me3 and suggest that these two
methyl marks have distinct functions in the cell.
Consistent with SRI regulating H3K36me3, several other
transcription complexes or kinases have been shown to regu-
late H3K36 trimethylation, notably the PAF and BUR kinase
complexes (46, 49). Prelich and co-workers demonstrated sev-
eral years ago that deletion of several PAF complex members,
cdc73, ctr9, or paf1, resulted in a decrease in H3K36me3
(49). Similarly, Jaehning and co-workers showed that CTD Ser2
phosphorylation is reduced in these same three PAFmutants (44).
Our data show that Set2 protein levels are also decreased in
cdc73, ctr9, and paf1 strains (Fig. 3B). We take these data to
conclude that decreased CTD phosphorylation in PAF mutants
results in reducedSet2protein levelswhichultimately changes the
balance of H3K36 methylation in the cell. Consistent with PAF
effectsofSer2phosphorylation,wealso seeadecreaseofSet2 levels
in BUR2 deletions (data not shown). Given that Bur1/Bur2 has
recently been demonstrated to function on both Spt5 (DSIF) and
theCTD (50), it is plausible that Bur1 also affectsH3K36me3/Set2
FIGURE 5. Proposed model of Set2 regulation. Set2 is in equilibrium between a free state and association with the hyperphosphorylated form of RNAPII. The
free form of Set2 is degraded in a proteasome-dependent manner with a half-life in yeast of 9 min. In its free form, Set2 is capable of dimethylation of H3K36,
which is sufficient for the recruitment of the repressive Rpd3(S) complex. Binding to RNAPII is required for H3K36me3, which may perform a positive function
in transcription elongation.
TABLE 1
Tetrad analysis of set2 mutant strains with htz1 and swr1
Mutant Tetrads Viable double mutant spores
%
swr1x
SET2 12 100 (12/12)
SET2(1–261) 14 0 (0/15)
set2 13 100 (15/15)
htz1x
SET2 20 100 (15/15)
SET2(1–261) 14 0 (0/13)
set2 18 11 (2/19)
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levels bydirectly influencingSer2 phosphorylationand/or through
DSIF recruitment of the PAF complex.
In our analysis of Set2 regulation, we noted that Set2 protein
turnoverwas reduced in a temperature-sensitive allele of a protea-
some subunit.We take these data to suggest that Set2 is degraded
via the proteasome (Fig. 2). Consistent with this notion, our data
are in agreement with a high throughput study of protein stability
where it was predicted that Set2 is an unstable protein (51). How-
ever, perhaps due to the rapid turnover of Set2 or the relatively
small amounts of enzyme normally found in cells, we have been
unable to identify a ubiquitin ligase, ubiquitin protease, or a site of
ubiquitin attachment to Set2 (data not shown).
A significant question to then ask is why would cells need to
dynamically regulate Set2 levels? In addition to providing a
rapidmeans of regulatingH3K36 di- and trimethylation during
logarithmic cell growth, the control of Set2 levels might have a
role in the response to cellular stress asmentioned above,where
the transient changes in H3K36 methylation may alter recruit-
ment of the repressor Rpd3(S) to sites of transcription to alle-
viate chromatin repression during transcription as proposed in
Fig. 5. This would explainwhy deletion of SET2 is able to bypass
a number of transcription elongation mutations including
mutations in Spt6, Spt16, and Bur1/2 (11, 14, 45). In this sce-
nario, removal of Set2 and hence both H3K36me2/me3, would
result in more open chromatin structure and improved tran-
scription of stress-response genes. In support of this idea, stud-
ies have shown that a wide number of stress-response genes are
up-regulated in a SET2 deletion (47).
As mentioned above, the ability to rapidly alter Set2 levels to
control the balance of H3K36me2 and H3K36me3 supports the
idea that H3K36me2 and H3K36me3 have different biological
functions. To explore this possibility further, we examined the
genetic interactions of a Set2 fragment that shows an inability to
catalyze H3K36me3 (Set2(1–261)). Importantly, this Set2 frag-
ment is properly recruited to gene coding regions in a transcrip-
tion-dependent manner (14). Our study compared the Set2(1–
261) fragment against wild-type Set2, where all three methylation
states atH3K36arepresent, andaSET2deletion,wherenoH3K36
methylation is observed. We found that Set2(1–261) shows dis-
tinct genetics from either deletion of SET2 or the wild-type case
when crossed withmutations in other factors important for chro-
matin structure and/or transcription elongation. This is particu-
larly significant because Set2(1–261) exhibits partial function.
This could be attributed to an imbalance in the levels of H3K36
methylation and supports that Set2 has both positive and negative
roles in regulating transcription. For example, a lackofH3K36me3
could lead to increased recruitment of repressive factors such as
Rpd3(S) to H3K36me2, or it may result in the inability to recruit
effector proteins that recognize H3K36me3. Interestingly, Eaf3,
the factor that recognizes H3K36me in the Rpd3(S) complex, is
also an integral member of the NuA4 histone acetyltransferase
complex. Furthermore, evidence shows that a member of the
NuA3 histone acetyltransferase complex also interacts with
H3K36me3 (and this complex is known to associatewith chroma-
tin in a Set2-dependent manner) (19, 20). Perhaps then,
H3K36me3 recruits activating complexes such as NuA3 and
NuA4 to certain genes to facilitate transcription, andmethylation
at H3K36 can act as both an activating and repressive mark, as is
seenwith lysinemethylation atH3K4 (52, 53). If thiswere the case,
it is possible that, in response to changes in CTDphosphorylation
causedby anenvironmental cueor transcriptional stress, degrada-
tion of Set2, rather than just disruption of the interaction between
Set2 and theCTD is necessary tomaintain someproper balance of
H3K36me2/me3 in the cell. AsKeogh et al.proposed several years
ago, such amechanismmight also be used to attenuate regulation
ofcertaingenesorcontrol transcription fromnormally silentcryp-
tic promoters (11).
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